RFPi raises $2m angel round for blood flow imaging tech

Early stage medical imaging company RFPi said today it raised $2 million in an angel investor financing round to support developing a commercial-scale model of its real-time, non-invasive medical imaging device.

The company is developing an imaging device designed to show blood flow in vascular structures and critical tissues in real time for use during surgery. The device operates around the company’s copyrighted iCertainty platform which allows for visualization and quantification of blood flow and perfusion without injection, dyes, radiation or direct patient contact, RFPi said.

“Angel investors — who see ideas for new medical devices all the time — recognized the potential for our device to permanently advance non-invasive medical imaging in terms of speed, ease of use and safety. We are grateful for their show of support and excited about moving toward achieving our key corporate milestones. In today’s health-care environment, it’s not enough for new medical devices to be clinically effective only. RFPi’s iCertainty technology can deliver brand-new information that adds value to the health-care system by improving outcomes and reducing costs,” CEO Jeff Basham said in a press release.

Working prototypes of the device have already been used in pre-clinical trials for over 3 years, the company said. RFPI said it expects to submit a Class II 510(k) application with the FDA by early 2017.

Technology at use in RFPi’s flagship device was originally invented in 2010 at East Carolina University, the company said, with development including bench-top and experimental studies, clinical proof-of-concept studies and validation studies.

The money raised in the round is the 1st part of a planned $3.5 million equity round, the Greenville, N.C.-based company said.

The post RFPi raises $2m angel round for blood flow imaging tech appeared first on MassDevice.

from MassDevice http://ift.tt/2cDOPwD